来自:中国糖尿病杂志 编辑:朱慧静 杨明明 程霖等|点击数:|2015-08-26
·糖尿病性肾脏疾病·
【摘要】 目的 探讨不同程度糖尿病慢性肾脏疾病(CKD)患者血清YKL-40水平的变化及其临床意义。 方法 按照UAlb/Cr水平将70例T2DM患者分为UAlb/Cr<30 mg/24 h组23例、UAlb/Cr 30~299 mg/24 h组24例和UAlb/Cr≥300 mg/24 h组23例,另选体检健康者20名作为健康对照(NC)组。采用ELISA检测血清YKL-40水平。 结果 T2DM各亚组血清YKL-40水平均高于NC组,且随UAlb/Cr水平增加而增加,各组间比较差异均有统计学意义(P<0.01)。血清YKL-40水平与病程、FPG、HbA1c、FIns、胰岛素抵抗指数(HOMA-IR)、UAlb/Cr、血肌酐(Scr)呈正相关(r=0.525、0.396、0.427、0.588、0.551、0.815、0.785,P<0.05),与eGFR呈负相关(r=-0. 819,P<0.05)。Logistic回归分析显示,YKL-40是T2DM患者肾功能损伤的独立危险因素。 结论 YKL-40可能参与CKD发生发展,可在一定程度上反映CKD肾功能损伤程度。
【关键词】 糖尿病,2型;糖尿病慢性肾脏疾病;YKL-40
The changes and clinical significance of serum YKL-40 level in type 2 diabetic patients with chronic kidney disease ZHU Hui-jing,YANG Ming-ming,CHENG Lin,et al. Department of Endocrinology,Heze Municipal Hospital,Heze 274000,China
Corresponding author:CHENG Xing-bo,E-mail:huijing1012@126.com
【Abstract】 Objective To explore the changes and clinical significance of serum YKL-40 levels in T2DM with chronic kidney disease (CKD). Methods 70 T2DM patients were divided into three groups according to UAlb/Cr level:23 cases with UAlb/Cr<30 mg/24 h,24 cases with UAlb/Cr 30~299 mg/24 h,23 cases with UAlb/Cr≥300 mg/24 h. 20 healthy subjects were chosen as normal control (NC) group. Serum YKL-40 levels were detected by ELISA. Results Serum YKL-40 levels in each T2DM subgroup were significantly higher than NC group. With the increase of UAlb/Cr,the YKL-40 levels increased (P<0.01). Correlation analysis showed that serum YKL-40 was associated with duration,FPG,HbA1c,FIns,HOMA-IR,UAlb/Cr,Scr and eGFR (r=0.525,0.396,0.427,0.588,0.551,0.815,0.785,-0.819,P<0.05).Logistic regression analysis showed that the level of serum YKL-40 was an independent risk factor for renal impairment in T2DM patients. Conclusion YKL-40 may be involved in the development and progression of CKD,and can reflect the degree of renal impairment in some extent.
【Key words】 Diabetes mellitus,type 2;Chronic kidney disease (CKD) in diabetes;
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想